Back

Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention: a systematic review and individual patient data network meta-analysis.

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Updates on single and combined antithrombotic therapy Antiplatelet Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Assistant Professor Mauro Chiarito

Clinical Institute Humanitas IRCCS, Rozzano (Italy)

Photo
Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
Effect of combined antiplatelet and anticoagulant therapy in comparison to anticoagulants in monotherapy on CABG outcomes in patients requiring anticoagulants. Analysis of real-world data.
Doctor A. Segiet-Swiecicka (Warsaw, PL)
Abstract Slides
Presentation thumbnail
BRIDGE: a barrier‑informed Bayesian risk prediction model for risk identification, trajectory grouping, and profiling of non‑adherence to cardioprotective medicines in primary care
Doctor H. Koh (Melbourne, AU) Assistant Professor S. Talic (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Bleeding and mortality risks after intravenous alteplase in stroke patients with prior dual antiplatelet therapy: a nationwide cohort study
Doctor H. Huang (Hualien, TW)
Abstract Slides
Presentation thumbnail
Single vs. dual antithrombotic therapy in patients with stabilized coronary artery disease requiring long-term oral anticoagulation: A Bayesian meta-analysis
Doctor P. Sabouret (Paris, FR)
Abstract Slides
Presentation thumbnail
Genotype-guided antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.
Doctor A. Buffon (Rome, IT)
Abstract Slides

Access the full session

Session thumbnail
Updates on single and combined antithrombotic therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients
27 August 2021
thumbnail
Congress Presentation
A new clinical decision support tool based on personalized evidence-based medicine improves outcomes of anticoagulation therapy in patients with atrial fibrillation: an analysis from the AF Registry
29 June 2021
thumbnail
Congress Presentation
Use of direct oral anticoagulants in patients with atrial fibrillation and cancer: a subanalysis of the nationwide Italian START registry.
20 June 2025
thumbnail
Congress Presentation
Comparing novel oral anticoagulants to vitamin k antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation: an updated systematic review and meta-analysis
7 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources